A state-of-the-art multi-criteria model for drug benefit-risk analysis T. Tervonen (1,*), H.L. Hillege (2, 3), E. Buskens (2), D. Postmus[removed]Faculty of Economics and Business, University of Groningen, PO Box 800, 97 - Multi-criteria decision analysis - Document - PDFSEARCH.IO

First Page	Meta Content
	A state-of-the-art multi-criteria model for drug benefit-risk analysis T. Tervonen (1,*), H.L. Hillege (2, 3), E. Buskens (2), D. Postmus[removed]Faculty of Economics and Business, University of Groningen, PO Box 800, 97 Add to Reading List Document Date: 2013-12-04 08:49:48 Open Document File Size: 172,87 KB Share Result on Facebook Country Netherlands / / / Facility University of Groningen / University Medical Center Groningen / / IndustryTerm insurance / / MedicalCondition insomnia / mild depression / severe depression / headache / diarrhea / less insomnia / dizziness / Depression / nausea / / MusicGroup Nausea / / Organization University of Groningen / Faculty of Economics and Business / Department of Epidemiology / Department of Cardiology / / / Position multi-criteria model for drug benefit-risk analysis / Model for the therapeutic group / multi-criteria model for the therapeutic group / Corresponding author / / Product Venlafaxine / Fluoxetine / / ProgrammingLanguage Java / / Technology simulation / Java / / URL http / SocialTag Organic chemistry Psychiatry Organofluorides Operations research Organochlorides Multi-criteria decision analysis Venlafaxine Antidepressant Major depressive disorder Decision theory

A state-of-the-art multi-criteria model for drug benefit-risk analysis T. Tervonen (1,*), H.L. Hillege (2, 3), E. Buskens (2), D. Postmus[removed]Faculty of Economics and Business, University of Groningen, PO Box 800, 97Add to Reading List